Advertisement
open access
Medical Conferences

Medical Conferences

  • Conference Reports
    • 2022 Medicom Conference Planning
  • Conference Proceedings
  • Disease Areas
  • Other Medical News
  • Podcast
  • Videos
  • Education
  • About
    • Vacancies

Tag: Tumour Necrosis Factor

New insights into psoriasis comorbidity

Presented By
Prof. Joel Gelfand, University of Pennsylvania, USA
Conference
AAD 2022

17 May, 2022 12:12

TNF inhibitor for immune-mediated inflammatory disease doubles the risk of paradoxical psoriasis

Presented By
Dr Nikolai Loft, Copenhagen University Hospital, Denmark
Conference
PFGC 2021

3 February, 2022 15:08

The Yin and Yang of opposing vectors: an explanation for side effects of biologics

Presented By
Prof. Curdin Conrad, Lausanne University Hospital, Switzerland
Conference
PFGC 2021

3 February, 2022 11:07

Explaining arthropathy development through IL-4 and IL-13 blockade

Presented By
Dr Charlie Bridgewood, University of Leeds, UK
Conference
PFGC 2021

3 February, 2022 10:51

TNF blockers likely beneficial for psoriatic patients with COVID-19

Presented By
Prof. Catherine Smith, King’s College London, UK
Trial
PsoProtect
Conference
PFG 2021

2 February, 2022 15:42

Patients on immunomodulators need 2 COVID-19 vaccinations before seroconversion

Presented By
Dr Ali Al-Janabi, University of Manchester, UK
Conference
PFGC 2021

2 February, 2022 15:22

Why antipsychotics cause weight gain

Presented By
Prof. Louise Gallagher, University of Dublin, Ireland
Conference
ECNP 2021

26 November, 2021 11:18

Existing and upcoming small molecules in psoriasis

Presented By
Dr Enikö Sonkoly , Karolinska University Hospital, Sweden
Trial
POETYK PSO; PSOARING
Conference
EADV 2021

18 November, 2021 13:19

Grand debate: Is psoriasis a systemic or skin-only disease?

Presented By
Prof. Brian Kirby & Prof. Stefano Piaserico
Conference
EADV 2021

18 November, 2021 13:14

COVID-19 and inflammatory rheumatic disease: some key issues

Presented By
Prof. G. Burmester, Charité University Hospital, Germany
Conference
EULAR 2020

14 August, 2020 15:06

Worse response axSpA patients to second TNFi versus first TNFi

Presented By
Dr Santiago Rodrigues-Manica, Hospital Egas Moniz, Portugal
Conference
EULAR 2020

14 August, 2020 10:27

AxSpA real-life remission rates higher on biologics

Presented By
Dr Charlotte Baert, Saint Luc University Hospital, Belgium
Conference
EULAR 2020

14 August, 2020 10:24

Certolizumab pegol reduces acute anterior uveitis in axial spondyloarthritis

Presented By
Prof. Irene van der Horst-Bruinsma, Amsterdam University Medical Center, the Netherlands
Trial
C-VIEW
Conference
EULAR 2020

14 August, 2020 10:19

TNF-α inhibitors improve bone mineral density in AS patients

Presented By
Mark Siderius, University Medical Center Groningen; Medical Center Leeuwarden, the Netherlands
Conference
EULAR 2020

14 August, 2020 10:13

Experimental model for limitations of haematopoietic stem cells propagation

Presented By
Dr Jennifer Myers SanMiguel, The Jackson Laboratory, USA
Conference
ASH 2019

5 March, 2020 14:47

Few serious infections in offspring with exposure to non-TNFi biologics or tofacitinib

Presented By
Dr Evelyne Vinet, McGill University, Montreal, Canada
Conference
ACR 2019

4 February, 2020 23:12

Tocilizumab outperforms rituximab in RA patients with low level of synovial B cell infiltration

Presented By
Prof. Costantino Pitzalis, Barts and The London School of Medicine and Dentistry, UK
Conference
ACR 2019

4 February, 2020 20:10

TNFi for RA during pregnancy – to stop or not to stop?

Presented By
Dr Isabell Haase, Heinrich-Heine University Düsseldorf, Germany
Conference
ACR 2019

4 February, 2020 10:16

Inflammation may change the course of Parkinson’s disease

Presented By
Prof. Vidar Gundersen, University of Oslo, Norway
Conference
EAN 2019

27 September, 2019 23:47

Biologicals beyond TNF blockade

Presented By
Prof. Brian Kirby, St. Vincent’s University Hospital, Ireland
Conference
WCD 2019

26 August, 2019 11:11

Advances in target-oriented therapy: psoriatic arthritis

Presented By
Prof. Wolf-Henning Boehncke, University of Geneva, Switzerland
Trial
ECLIPSA, TICOPA
Conference
10:14:19pm> hello nurse from conference

21 June, 2019 23:48

Results from the ECLIPSE trial: does blocking IL-23 have better long-term outcomes in psoriasis?

Presented By
Prof. Kristian Reich, Georg-August-University Göttingen, Germany
Trial
ECLIPSE
Conference
SPIN 2019

21 June, 2019 18:23

Small molecules, apremilast, and TYK2

Presented By
Prof. Richard Langley, Dalhousie University, Canada
Trial
ESTEEM, PALACE, LIBERATE
Conference
SPIN 2019

21 June, 2019 09:45

Molecular effects of ustekinumab

Trial
Phase 3, UNITI
Conference
ECCO 2019

9 May, 2019 19:47

Gene expression signature predicts non-response

Trial
ACT1, PURSUIT-SC, PROgECT, PURSUIT-J, UNITI
Conference
ECCO 2019

9 May, 2019 18:48


Register to view our latest news directly from the conference and receive news notifications in your field.

Register Now
site created by:   

© 2021 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy